P. Mäkelä

Chemical castration induced by adjuvant cyclophosphamide, methotrexate, and fluorouracil chemotherapy causes rapid bone loss that is reduced by clodronate: a randomized study in premenopausal breast cancer patients.

Tiina Saarto, Carl Blomqvist, M Välimäki et al. · Journal of Clinical Oncology · 1997 · 264 citations

Long-term impact of chemotherapy-induced ovarian failure on bone mineral density (BMD) in premenopausal breast cancer patients. The effect of adjuvant clodronate treatment

Leena Vehmanen, Tiina Saarto, Inkeri Elomaa et al. · European Journal of Cancer · 2001 · 133 citations

Bone Disease, Chemotherapy-induced Ovarian Failure, Adjuvant Clodronate Treatment +12

Clodronate improves bone mineral density in post-menopausal breast cancer patients treated with adjuvant antioestrogens

Tiina Saarto, Carl Blomqvist, M Välimäki et al. · British Journal of Cancer · 1997 · 119 citations · Full text

Adjuvant Antioestrogens, Bone Disease, Bone Health +13

A prospective study of bone loss and turnover after allogeneic bone marrow transplantation: effect of calcium supplementation with or without calcitonin

MJ Välimäki, Kati Kinnunen, Liisa Volin et al. · Bone Marrow Transplantation · 1999 · 117 citations

Bone Loss, Calcium Supplementation, Bone Health +8

Bone Mass and Markers of Bone and Calcium Metabolism in Postmenopausal Women Treated with 1,25-Dihydroxyvitamin D (Calcitriol) for Four Years

S. Sairanen, M Kärkkäinen, Riitta Tähtelä et al. · Calcified Tissue International · 2000 · 52 citations

Bone Disease, Nutrition, Bone Health +12